1. Home
  2. Stocks
  3. Hesterbio Share Price
  • Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Hester Biosciences Share Price

    Small Cap
    ₹2,453.25
    + 19.85 (0.82%)
    18 September, 2024 02:39 BSE: 524669 NSE: HESTERBIO ISIN: INE782E01017

    Start SIP in Hester Biosciences

    Start SIP

    Hester Biosciences Performance

    Day Range

    • Low 2,414
    • High 2,471
    ₹ 2,453

    52 Week Range

    • Low 1,293
    • High 3,379
    ₹ 2,453
    • Open Price2,448
    • Previous Close2,433
    • Volume3583

    Hester Biosciences Chart

    • Over 1 Month -3.08%
    • Over 3 Month + 29.74%
    • Over 6 Month + 82.83%
    • Over 1 Year + 41.29%

    Hester Biosciences Key Statistics

    P/E Ratio 107.8
    PEG Ratio -3.4
    Market Cap Cr
    Price to Book Ratio 6.9
    EPS 31.9
    Dividend 0.2
    Relative Strength Index 48.2
    Money Flow Index 56.12
    MACD Signal -49.45
    Average True Range 103.83

    Hester Biosciences Investment Rating

    • Master Rating:

    • Hester Biosciences has an operating revenue of Rs. 298.96 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of 9% is okay, ROE of 6% is fair but needs improvement. The company has a debt to equity of 62%, which is bit higher. The stock from a technical standpoint is trading below to its 50DMA and around 29% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 44 which is a POOR score indicating inconsistency in earnings, a RS Rating of 74 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 13 indicates it belongs to a strong industry group of Medical-Ethical Drugs and a Master Score of B is close to being the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Hester Biosciences Financials
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 737366668061
    Operating Expenses Qtr Cr 606054546950
    Operating Profit Qtr Cr 131212121111
    Depreciation Qtr Cr 223333
    Interest Qtr Cr 111110
    Tax Qtr Cr 332223
    Net Profit Qtr Cr 876766
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 289259
    Operating Expenses Annual Cr 238199
    Operating Profit Annual in Cr 4755
    Depreciation Cr 1010
    Interest Annual Cr 56
    Tax Annual Cr 1012
    Net Profit Annual Cr 2732
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 4333
    Cash from Investing Activity Annual Cr -21-72
    Cash from Financing Annual Activity Cr -2441
    Net Cash Flow Annual Cr -23
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 313292
    Fixed Assets Annual Cr 275257
    Total Non Current Assets Annual Cr 345330
    Total Current Assets Annual Cr 204216
    Total Assets Annual Cr 550546
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 368344
    ROE Annual % 911
    ROCE Annual % 912
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1824
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 827967708867
    Operating Expenses Qtr Cr 656357577356
    Operating Profit Qtr Cr 181610131412
    Depreciation Qtr Cr 444455
    Interest Qtr Cr 572831
    Tax Qtr Cr 332323
    Net Profit Qtr Cr 654465
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 315281
    Operating Expenses Annual Cr 251215
    Operating Profit Annual in Cr 5451
    Depreciation Cr 1721
    Interest Annual Cr 209
    Tax Annual Cr 1112
    Net Profit Annual Cr 1927
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 4824
    Cash from Investing Activity Annual Cr -23-77
    Cash from Financing Annual Activity Cr -2642
    Net Cash Flow Annual Cr -1-12
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 292280
    Fixed Assets Annual Cr 412408
    Total Non Current Assets Annual Cr 448442
    Total Current Assets Annual Cr 215228
    Total Assets Annual Cr 662670
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 356339
    ROE Annual % 610
    ROCE Annual % 89
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 2125
    Invest in Hester Biosciences

    Hester Biosciences Technicals

    EMA & SMA

    Current Price
    ₹2,453.25
    + 19.85 (0.82%)
    pointer
    • Bullish Moving Average
    • ___
    • 11
    • Bearish Moving Average
    • ___
    • 5
    • 20 Day
    • ₹2,457.93
    • 50 Day
    • ₹2,465.81
    • 100 Day
    • ₹2,302.83
    • 200 Day
    • ₹2,073.09
    • 20 Day
    • ₹2,431.80
    • 50 Day
    • ₹2,615.94
    • 100 Day
    • ₹2,280.04
    • 200 Day
    • ₹1,879.04

    Hester Biosciences Resistance and Support

    PIVOT
    ₹2,446.09
    Resistance
    First Resistance 2,478.17
    Second Resistance 2,503.08
    Third Resistance 2,535.17
    RSI 48.20
    MFI 56.12
    MACD Single Line -49.45
    MACD -40.46
    Support
    First Support 2,421.17
    Second Support 2,389.08
    Third Supoort 2,364.17

    Hester Biosciences Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 3,921 159,193 40.6
    Week 6,592 345,487 52.41
    1 Month 9,330 424,789 45.53
    6 Month 18,555 809,195 43.61

    Hester Biosciences Result Highlights

    Hester Biosciences Synopsis

    NSE-Medical-Ethical Drugs

    Hester Biosciences L is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 285.16 Cr. and Equity Capital is Rs. 8.51 Cr. for the Year ended 31/03/2024. Hester Biosciences Ltd. is a Public Limited Listed company incorporated on 29/04/1987 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L99999GJ1987PLC022333 and registration number is 022333.
    Market Cap 2,070
    Sales 278
    Shares in Float 0.39
    No of funds 14
    Yield 0.25
    Book Value 6.62
    U/D Vol ratio 1.5
    LTDebt / Equity 25
    Alpha 0.07
    Beta 0.88

    Hester Biosciences Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23Sep-23
    Promoters 53.73%53.73%53.73%53.73%
    Mutual Funds
    Foreign Portfolio Investors 0.52%0.43%0.43%0.42%
    Individual Investors 32.63%33.33%33.3%33.19%
    Others 13.12%12.51%12.54%12.66%

    Hester Biosciences Management

    Name Designation
    Dr. Bhupendra Gandhi Chairman
    Mr. Rajiv Gandhi Managing Director & CEO
    Ms. Priya Gandhi Executive Director
    Mr. Ravin Gandhi Director
    Mr. Sanjiv Gandhi Director
    Mr. Ashok Bhadakal Independent Director
    Ms. Sandhya Patel Independent Director
    Mr. Ameet Desai Independent Director
    Mr. Anil Jain Independent Director
    Mr. Jatin Trivedi Independent Director
    Ms. Nina Gandhi Alternate Director

    Hester Biosciences Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Hester Biosciences Corporate Action

    Date Purpose Remarks
    2024-08-02 Quarterly Results
    2024-05-10 Audited Results & Dividend
    2024-02-02 Quarterly Results
    2023-11-07 Quarterly Results
    2023-08-08 Quarterly Results

    Hester Biosciences MF Shareholding

    Name Amount(cr)

    Hester Biosciences FAQs

    What is Share Price of Hester Biosciences ?

    Hester Biosciences share price is ₹2,453 As on 18 September, 2024 | 02:25

    What is the Market Cap of Hester Biosciences ?

    The Market Cap of Hester Biosciences is ₹2087 Cr As on 18 September, 2024 | 02:25

    What is the P/E ratio of Hester Biosciences ?

    The P/E ratio of Hester Biosciences is 107.8 As on 18 September, 2024 | 02:25

    What is the PB ratio of Hester Biosciences ?

    The PB ratio of Hester Biosciences is 6.9 As on 18 September, 2024 | 02:25

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     
    footer_form

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 29/07/2024 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.